Glaxosmithkline Pharma net profit declines 33.73% in the September 2013 quarter

Sales decline 7.17% to Rs 620.54 crore

Net profit of Glaxosmithkline Pharma declined 33.73% to Rs 100.95 crore in the quarter ended September 2013 as against Rs 152.34 crore during the previous quarter ended September 2012. Sales declined 7.17% to Rs 620.54 crore in the quarter ended September 2013 as against Rs 668.50 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales620.54668.50 -7 OPM %18.3830.77 -PBDT153.43246.78 -38 PBT148.47241.94 -39 NP100.95152.34 -34

Powered by Capital Market - Live News